From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope ...
Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...
A retrospective registry analysis linked ischemic and hemorrhagic strokes to pollutant levels on the event day and prior two ...
Despite these declines, CRC incidence is rising in adults younger than 65, increasing by 3% per year among patients aged 20 ...
The gap in shared decision-making was similarly notable. Clinicians rated their own effectiveness in involving patients at 80 ...
Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% ...
For Patients With mCRPC, Results With Pluvicto in Real-World Settings Keep Pace With Clinical Trials
Real-world evidence shows Pluvicto matches pivotal trial benefits in PSMA-positive mCRPC, with longer PFS after one ARPI and ...
Advanced practice providers expand access by conducting initial consults, ordering diagnostic workups, explaining ...
Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, ...
AI-enabled coronary CT angiography reveals total plaque burden beyond calcium scores, improving risk prediction and personalizing cardiovascular prevention.
These results suggest that ruxolitinib cream offers high levels of clinical efficacy, including deep and rapid responses, ...
Jody L. Green, PhD, explains how regulatory decisions shape medication safety amid uptake of OTC drugs. Green also highlights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results